Enlivex Ltd.
ENLV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596812
No open-market purchases or sales by Enlivex Ltd. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $2.34M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q4 2021
Institutional positions in Enlivex Ltd. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +3 vs. Q3 2021
- Shares held
- 662.7K
- −185.1K (−21.8%) vs. Q3 2021
- Total value
- $4.12M
- −$4.27M (−50.9%) vs. Q3 2021
- New holders
- 6
- 4 more added
- Sold out
- 3
- 11 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENLV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $2.34M |
| Q1 2026 | 35 | $3.38M |
| Q4 2025 | 25 | $929.4K |
| Q3 2025 | 29 | $950.2K |
| Q2 2025 | 21 | $2.87M |
| Q1 2025 | 26 | $3.08M |
| Q4 2024 | 24 | $3.99M |
| Q3 2024 | 19 | $4.31M |
| Q2 2024 | 17 | $2.96M |
| Q1 2024 | 15 | $1.24M |
| Q4 2023 | 17 | $509.2K |
| Q3 2023 | 16 | $408.4K |
| Q2 2023 | 19 | $795.1K |
| Q1 2023 | 19 | $1.24M |
| Q4 2022 | 21 | $1.32M |
| Q3 2022 | 18 | $1.41M |
| Q2 2022 | 22 | $2.89M |
| Q1 2022 | 25 | $4.75M |
| Q4 2021 | 23 | $4.12M |
| Q3 2021 | 20 | $8.38M |
| Q2 2021 | 20 | $8.79M |
| Q1 2021 | 23 | $11.7M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Enlivex Ltd.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Captrust Financial Advisors | 25 | $0 | 0.00% | −1,000−97.6% | Reduced |
| Tower Research Capital LLC (TRC) | 65 | $0 | 0.00% | −121−65.1% | Reduced |
| Ahrens Investment Partners LLC | 50 | $0 | 0.00% | +50 | New |
| Advisor Group Holdings, Inc. | 400 | $3.00K | 0.00% | −1,800−81.8% | Reduced |
| Umb Bank N A | 550 | $3.00K | 0.00% | +550 | New |
| Harel Insurance Investments & Financial Services Ltd. | 519 | $3.00K | 0.00% | +519 | New |
| Steward Partners Investment Advisory, LLC | 3,000 | $17.0K | 0.00% | −12,500−80.6% | Reduced |
| Bank of America Corp | 3,296 | $21.0K | 0.00% | −389−10.6% | Reduced |
| Marshall Wace, LLP | 6,386 | $39.0K | 0.00% | +6,386 | New |
| Simplex Trading, LLC | 10,164 | $63.0K | 0.00% | +10,164 | New |
| Geode Capital Management, LLC | 10,420 | $65.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 11,284 | $71.0K | 0.00% | +11,284 | New |
| Wells Fargo & Company | 12,204 | $76.0K | 0.00% | −964−7.3% | Reduced |
| Edmond de Rothschild Holding S.A. | 13,000 | $81.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 17,161 | $107.0K | 0.00% | −1,382−7.5% | Reduced |
| State Street Corp | 19,863 | $124.0K | 0.00% | +1,371+7.4% | Added |
| Golden Green, Inc. | 19,967 | $125.0K | 0.10% | −24,118−54.7% | Reduced |
| UBS Group AG | 21,646 | $135.0K | 0.00% | +6,192+40.1% | Added |
| ACT Capital Management, LLC | 25,000 | $156.0K | 0.11% | −57,500−69.7% | Reduced |
| Jane Street Group, LLC | 27,700 | $173.0K | 0.00% | +16,639+150.4% | Added |
| Compagnie Lombard Odier SCmA | 43,000 | $247.0K | 0.00% | +8,000+22.9% | Added |
| Renaissance Technologies LLC | 67,689 | $423.0K | 0.00% | −20,300−23.1% | Reduced |
| ARK Investment Management LLCSuperinvestorARK Invest | 349,308 | $2.18M | 0.01% | −108,489−23.7% | Reduced |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,299−100.0% | Sold out |
| Brewin Dolphin Ltd | 0 | $0 | 0.00% | −249−100.0% | Sold out |
| Red Tortoise LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |